Clinical Evaluation of Flortaucipir F 18

PHASE2CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Alzheimer's DiseaseTraumatic Brain InjuryDepression
Interventions
DRUG

Flortaucipir F18

IV injection, 370 MBq (10 mCi), up to two doses

PROCEDURE

Brain PET scan

positron emission tomography (PET) scan of the brain

Trial Locations (5)

19104

University of Pennsylvania, Philadelphia

75235

Center for Vital Longevity at the University of Texas at Dallas, Dallas

85006

Banner Alzheimer's Institute, Phoenix

89106

Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas

06510

Yale University, New Haven

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY